1[1]Mefarlard LV.Risk factor for antibiotic associated diarrhea A review of the Literature[J].Ann Med Interne(Paris).1998,14∶261-266.
2[2]Chaturverdi N,SjolieA-K,Stephenson JM,et al.The effect of Lisinopril on the progression of retinopathy in normotensive people with type I diabetes[J].Lancet 1998,329∶1456.
3[3]Lewis EJ,Hun sicker,LG Bain RP,Rhode RD et al.The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl[J].J Med 1998,351∶28.
4[4]Malik RA Williamson S et al.Effect of angiotensin coveting-enzyme inhibitor trandolopril on human diabetic neuropathy:Randomized double blind controlled trail[J].Lancet 1998,352∶1978.
5[5]Garg R Yen surf S et al.Overview of randomized trials of angiotenisn-conveting enzyme inhibitors on mortality in patients with heart failure[J].JAMA 1995,273∶1450.
6[6]Cleland JGF,McGowan J,Clark A.The evidence for β-blockers in heart failure[J].BMJ 1999,7187∶824.
8[8]Klahr S.Levy As,et al.The effect of dietary protein restriction and blood pressure control on the progression of chronic disease[J].N Engl.J Meal 1994,330∶877.
9[9]Lazarus JM,Bourguignon JJ et al. Hypertension[J] 1997,29∶641.
10[10]Hoelscher D.Bakris G;Anti-hypertension therapy and progression of diabetic renal disease[J].J cardiovasc pharmacol 1994,23(1)∶S34-S38.
